# Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis

> **NCT01365793** · PHASE3 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 1389 (actual)

## Conditions studied

- Cerebral Edema
- Diabetic Ketoacidosis

## Interventions

- **DRUG:** 0.45% saline replacement fluid
- **DRUG:** 0.9% saline replacement fluid
- **DRUG:** 0.45% saline intravenous fluid
- **DRUG:** 0.9% saline Intravenous fluid

## Key facts

- **NCT ID:** NCT01365793
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2016-09
- **Final completion:** 2017-01
- **Target enrollment:** 1389 (ACTUAL)
- **Last updated:** 2018-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365793, "Randomized Control Trial of Fluid Therapy for Pediatric Diabetic Ketoacidosis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT01365793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*